CRIS Current Research Information System

RAMAZZOTTI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.189
AS - Asia 4.117
EU - Europa 3.745
AF - Africa 376
Continente sconosciuto - Info sul continente non disponibili 299
SA - Sud America 227
OC - Oceania 14
Totale 13.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.099
SG - Singapore 1.270
IT - Italia 1.122
VN - Vietnam 1.026
CN - Cina 993
GB - Regno Unito 620
DE - Germania 485
SE - Svezia 448
HK - Hong Kong 248
FR - Francia 196
IN - India 172
RU - Federazione Russa 168
BR - Brasile 147
UA - Ucraina 114
IE - Irlanda 113
TG - Togo 109
KR - Corea 102
NL - Olanda 92
FI - Finlandia 81
CI - Costa d'Avorio 76
ZA - Sudafrica 67
JP - Giappone 63
CA - Canada 58
SC - Seychelles 57
CH - Svizzera 44
EE - Estonia 41
AT - Austria 40
BG - Bulgaria 40
NG - Nigeria 38
BD - Bangladesh 34
AR - Argentina 32
HR - Croazia 31
PK - Pakistan 27
BE - Belgio 24
ID - Indonesia 24
PH - Filippine 23
PL - Polonia 23
JO - Giordania 21
TH - Thailandia 18
IQ - Iraq 16
GR - Grecia 14
ES - Italia 13
RO - Romania 12
TR - Turchia 12
MX - Messico 11
TW - Taiwan 10
UY - Uruguay 10
CO - Colombia 8
EC - Ecuador 8
MY - Malesia 8
UZ - Uzbekistan 8
AU - Australia 7
JM - Giamaica 7
CL - Cile 6
SA - Arabia Saudita 6
NZ - Nuova Zelanda 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
VE - Venezuela 5
IL - Israele 4
KE - Kenya 4
KZ - Kazakistan 4
LB - Libano 4
MD - Moldavia 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
DZ - Algeria 3
EG - Egitto 3
ET - Etiopia 3
LT - Lituania 3
MA - Marocco 3
NO - Norvegia 3
PS - Palestinian Territory 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BW - Botswana 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SS - ???statistics.table.value.countryCode.SS??? 2
SV - El Salvador 2
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CY - Cipro 1
GH - Ghana 1
Totale 13.659
Salva come PNG Salva come JPEG
Città #
Singapore 897
Ashburn 538
Southend 519
Chandler 429
Fairfield 427
Bologna 357
San Jose 285
Santa Clara 263
Houston 238
Hong Kong 232
Ho Chi Minh City 226
Hanoi 197
Woodbridge 185
Ann Arbor 184
Hefei 180
Seattle 177
Cambridge 157
Wilmington 157
Boardman 139
Princeton 138
Beijing 133
Dallas 118
Dublin 114
Lomé 109
Council Bluffs 107
Dong Ket 102
New York 81
Abidjan 76
Frankfurt am Main 71
Seoul 69
Lauterbourg 68
Jacksonville 66
Milan 58
Westminster 56
Los Angeles 54
Helsinki 53
Nanjing 53
Tokyo 50
Padova 49
Berlin 45
Sofia 40
Munich 38
San Diego 38
Bern 37
Turin 37
Florence 36
Abeokuta 35
Buffalo 35
Moscow 33
Jinan 32
Saint Petersburg 32
Parma 30
Haiphong 29
Redondo Beach 29
Rome 29
São Paulo 29
Guangzhou 28
Da Nang 26
Vienna 26
Changsha 25
Redwood City 25
Johannesburg 24
Redmond 24
Shenyang 24
Brussels 23
Bremen 22
Des Moines 22
Shanghai 22
San Francisco 21
Amman 20
London 20
Chicago 18
Sejong 18
Toronto 17
Medford 16
Nanchang 16
Orem 16
Udine 16
Warsaw 16
Bengaluru 14
Jakarta 14
Lappeenranta 14
Turku 14
Zhengzhou 14
Kunming 13
Rimini 13
The Dalles 13
Tianjin 13
Biên Hòa 12
Nuremberg 12
Paris 12
Phoenix 12
Atlanta 11
Hangzhou 11
Hebei 11
Mountain View 11
Dearborn 10
Falkenstein 10
Montreal 10
Mülheim 10
Totale 8.735
Salva come PNG Salva come JPEG
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 372
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 294
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 280
Inositide-Dependent Nuclear Signalling in Health and Disease 256
Cancer therapy and treatments during COVID-19 era 248
A role for PKCepsilon during C2C12 myogenic differentiation 243
K562 cell proliferation is modulated by PLCbeta1 through a PKCalpha-mediated pathway 238
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 227
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 227
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 225
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 218
Nuclear inositide signaling and cell cycle 213
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 213
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 213
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 211
Nuclear Inositide Signaling via Phospholipase C 210
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 209
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 209
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 208
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 208
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 206
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 205
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. 204
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 203
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 199
Revisiting nuclear phospholipase C signalling in MDS 198
Genotype of inflammatory cytokines in limbal stem cell graft in Italian patients. 196
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 196
Advances in MDS/AML and inositide signalling 195
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 191
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 191
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 191
Inositide signaling in the nucleus: From physiology to pathology. 188
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 188
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 187
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 186
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 186
Physiology and pathology of nuclear phospholipase C beta1 185
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. 184
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 181
Lamin B1 as a key modulator of the developing and aging brain 180
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 180
MiRNA-210: A Current Overview 179
Nuclear phospholipase C beta1 and cellular differentiation. 178
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 177
Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C 174
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 173
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 171
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula 170
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 165
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells 164
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 164
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 164
Modulation of nuclear PI-PLCbeta1 during cell differentiation 158
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 156
Understanding the Ultra-Rare Disease Autosomal Dominant Leukodystrophy: an Updated Review on Morpho-Functional Alterations Found in Experimental Models 155
The physiology and pathology of inositide signaling in the nucleus 155
Nuclear inositide signaling in myelodysplastic syndromes. 153
Nuclear PI-PLCbeta1-Lamin B1 complex signalling during cell cycle progression in human erytholeukemia cells 152
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression 152
Recent advances in MDS mutation landscape: Splicing and signalling 152
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression 151
Nuclear translocation of PKCα isoenzyme is involved in neurogenic commitment of human neural crest-derived periodontal ligament stem cells 150
Role of nuclear PLC and PI3K signaling in the development of cancer 149
null 144
Nuclear PI-PLC β1 and Myelodysplastic Syndromes: From Bench to Clinics 144
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 140
Nuclear PLCs affect insulin secretion by targeting PPARgamma; in pancreatic beta cells. 126
IPMK and β-catenin take part in PLC-β1-dependent signaling pathway during myogenic differentiation 118
Roles of p53, NF-kappa B and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 102
Nuclear phosphoinositides: location, regulation and function. 94
Inositide-dependent signal transduction in the nucleus: a virtuous path from the laboratory to the clinic 90
Phosphatidylinositol Turnover and Receptors 83
null 80
null 78
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells 74
Nuclear phospholipase C in biological control and cancer 70
null 65
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. 55
Totale 13.967
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.426 0 35 109 113 133 70 42 99 46 262 266 251
2022/20231.798 199 243 106 254 151 133 119 85 258 32 105 113
2023/2024658 26 91 83 64 69 105 40 31 32 38 31 48
2024/20252.034 87 253 209 127 336 108 188 97 49 112 106 362
2025/20264.516 385 495 424 302 559 250 490 133 850 291 173 164
2026/2027247 102 145 0 0 0 0 0 0 0 0 0 0
Totale 13.967